REVIEW OF SAFETY AND TOLERANCE OF OMALIZUMAB
The review of safety of monoclonal anti-ige-antibodies (xolair) — a new medication for the treatment of severe allergic bronchial asthma is presented. Local and system adverse events, originating after injection of medicament in clinical studies and following administration in patients are discussed...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2008-10-01
|
| Series: | Вопросы современной педиатрии |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/1462 |
| _version_ | 1797694916467359744 |
|---|---|
| author | A.V. Emel'yanov |
| author_facet | A.V. Emel'yanov |
| author_sort | A.V. Emel'yanov |
| collection | DOAJ |
| description | The review of safety of monoclonal anti-ige-antibodies (xolair) — a new medication for the treatment of severe allergic bronchial asthma is presented. Local and system adverse events, originating after injection of medicament in clinical studies and following administration in patients are discussed.Key words: children, bronchial asthma, monoclonal anti Ige antibodies. |
| first_indexed | 2024-03-12T03:04:47Z |
| format | Article |
| id | doaj.art-0cb417477ed8436e9e8b45cf4f483737 |
| institution | Directory Open Access Journal |
| issn | 1682-5527 1682-5535 |
| language | English |
| last_indexed | 2024-03-12T03:04:47Z |
| publishDate | 2008-10-01 |
| publisher | "Paediatrician" Publishers LLC |
| record_format | Article |
| series | Вопросы современной педиатрии |
| spelling | doaj.art-0cb417477ed8436e9e8b45cf4f4837372023-09-03T14:33:01Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352008-10-017587901462REVIEW OF SAFETY AND TOLERANCE OF OMALIZUMABA.V. Emel'yanov0Санкт-Петербургская медицинская академия последипломного образованияThe review of safety of monoclonal anti-ige-antibodies (xolair) — a new medication for the treatment of severe allergic bronchial asthma is presented. Local and system adverse events, originating after injection of medicament in clinical studies and following administration in patients are discussed.Key words: children, bronchial asthma, monoclonal anti Ige antibodies.https://vsp.spr-journal.ru/jour/article/view/1462 |
| spellingShingle | A.V. Emel'yanov REVIEW OF SAFETY AND TOLERANCE OF OMALIZUMAB Вопросы современной педиатрии |
| title | REVIEW OF SAFETY AND TOLERANCE OF OMALIZUMAB |
| title_full | REVIEW OF SAFETY AND TOLERANCE OF OMALIZUMAB |
| title_fullStr | REVIEW OF SAFETY AND TOLERANCE OF OMALIZUMAB |
| title_full_unstemmed | REVIEW OF SAFETY AND TOLERANCE OF OMALIZUMAB |
| title_short | REVIEW OF SAFETY AND TOLERANCE OF OMALIZUMAB |
| title_sort | review of safety and tolerance of omalizumab |
| url | https://vsp.spr-journal.ru/jour/article/view/1462 |
| work_keys_str_mv | AT avemelyanov reviewofsafetyandtoleranceofomalizumab |